Recent Updates
Recently added Catalysts
GILD Positive Sentiment

Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia

Key Takeaway: Gilead Foundation has announced a $12 million investment aimed at enhancing HIV prevention efforts through community health workers across 14 states and the District of Columbia. This initiative focuses on empowering local organizations to provide tailored education and services to communities most affected by HIV. The funding will support integrated screening and reduce stigma while building long-term capacity in the community health workforce.
Price reaction · baseline $148.95 (2026-02-27 close) · hit pre-market · clean, no other GILD news in the window
day 0 close · peak
+0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Gilead Foundation invests $12 million to enhance HIV prevention.
  • Empowers community health workers to improve access to care.
  • Targets communities disproportionately affected by HIV.
  • Strengthens local organizations and infrastructure for sustainable impact.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+15%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Ranolazine
Phase 2 · Diabetes Mellitus, Type 2

Full Press Release Details

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Foundation today announced a $12 million investment in 33 community‑based organizations across 14 states and the District of Columbia through its Community Health Worker (CHW) Comprehensive HIV Prevention Initiative. This two‑year effort expands CHW‑led prevention models that strengthen knowledge, care navigation, and access to services for communities disproportionately affected by HIV.
GILEAD FOUNDATION AWARDS $12 MILLION TO EMPOWER COMMUNITY HEALTH WORKERS AND EXPAND HIV PREVENTION INITIATIVES ACROSS 14 STATES AND THE DISTRICT OF COLUMBIA
“Community health workers are often the first and most trusted point of connection for people seeking information, support and care,” said Keeley Cain Wettan, Executive Vice President, General Counsel, Legal and Compliance at Gilead Sciences and a Board Member of Gilead Foundation. “Advancing HIV prevention requires both medical innovation and strong, community-led systems that address the social and structural barriers people face every day. By investing in community-based organizations, we’re helping expand access to trusted information, screenings, and culturally responsive care that can drive more equitable health outcomes.”
The initiative also strengthens organizational infrastructure and CHW training systems to build sustainable, locally driven HIV‑prevention networks. It prioritizes communities most impacted by HIV—including Black and Latino communities who have sex with men (MSM); cisgender and transgender women; people who inject drugs; and youth—by delivering tailored education and prevention services.
The 33 recipient organizations represent a diverse range of communities facing ongoing HIV prevention challenges. Awardees demonstrate strong community trust, thoughtful program design, and clear plans for measurable impact. Many will use culturally aligned approaches such as promotores models, support, and navigation services within Latino communities, along with peer ambassadors and youth‑focused programming.
Philadelphia‑based grantee Bebashi – Transition to Hope, which works to advance health equity in the communities it serves, shared its enthusiasm for the initiative. “Bebashi is ecstatic to receive this grant from Gilead Foundation which will strengthen our efforts through the Community Health Worker Initiative,” said Frank Franklin, Ph.D., J.D., M.P.H., FCPP, Chief of Strategic Initiatives. “Community health worker professionals complement Bebashi’s mission of community responsiveness and holistic support.”
Over the next two years, funded organizations will work to:
Expand integrated screening for HIV, STIs, mental health, and substance use
Deliver targeted HIV prevention education
Connect people to services, including HIV prevention, harm reduction resources, and other supportive care
Reduce stigma and strengthen community engagement through trusted massagers
Grantee Allies in Hope, a Houston‑based nonprofit providing HIV prevention, testing, and supportive services to communities disproportionately impacted by HIV, emphasized the role of connection in prevention. “When communities are supported, informed, and empowered, pathways to hope become pathways to healing,” said Jeffrey Campbell, Chief Executive Officer. “Our mission to end the HIV epidemic in the greater Houston area will be significantly bolstered through this funding.”
Many programs will also strengthen the community health workforce through peer navigator models, apprenticeships, pharmacy‑based training, and community health integration across care settings, building long‑term capacity beyond the grant period.
Grantees
AlabamaFive Horizons Health ServiceThrive AlabamaArizonaAssociation (NPhA)Prisma Community CareNational PharmaceuticalCaliforniaBienestar Human ServicesRealistic Education in Action Coalition to Foster Health (R.E.A.C.H. LA)St. John’s Community HealthThe TransLatin@ CoalitionColoradoServicios de La RazaFloridaLGBT+ Center OrlandoOceana Community Health, IncPrevention 305The Poverello Center, Inc. GeorgiaNAESM, IncIllinoisChicago Family Clinic, IncLouisianaCrescentCareMichiganCommunity Health Awareness Group (CHAG)New YorkCallen-Lorde Community Health CenterVoces Latinas CorporationCicatelli Associates, Inc. (CAI) programs nationwideGay Men’s Health Crisis (GMHC)Trillium Health, Inc OhioEquitas HealthPennsylvaniaBebashi – Transition to HopeMazzoni CenterTexasAbounding Prosperity, Inc.Allies in HopePrism Health North TexasPILLARResource Center of Dallas, Inc.Washington, DCLa Clínica del Pueblo, Inc.Whitman-Walker Health

About the Gilead Foundation

The Gilead Foundation is a nonprofit organization that works to create a thriving health ecosystem. The Gilead Foundation takes a holistic approach to mitigate the root causes of health inequities by providing resources to organizations that empower people with the skills to be their own best advocate and create systems of support that strengthen communities, classrooms and workplaces

About Gilead Sciences

Gilead Sciences, Inc. (Nasdaq: GILD) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
For more information about Gilead, please visit the company’s website atwww.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).

Frequently Asked Questions

What is the purpose of Gilead's $12 million investment?

The investment aims to enhance HIV prevention initiatives through community health workers.

Which communities are prioritized in this initiative?

The initiative focuses on communities disproportionately affected by HIV, including Black and Latino populations.

How will the funding impact local organizations?

The funding will strengthen organizational infrastructure and support sustainable HIV prevention networks.

What services will funded organizations provide?

They will deliver HIV prevention education, integrated screenings, and connect people to supportive services.

What is the role of community health workers in this initiative?

Community health workers will provide trusted information, care navigation, and culturally responsive support.

Last updated: Mar 2, 2026